Search Results

Your search matched 89 results

#1

Psychiatric Trials Supercharged by Otsuka’s Science 37 Collab | Blog

Holistic healthcare brand Otsuka Pharmaceutical has announced a promising partnership with Science 37, the trailblazing startup out of MIT that’s transforming clinical trials for everyone.

#2

Orphan Drugs More Promising than Ever | Blog

The growing appeal of orphan drugs to manufacturers isn’t a groundbreaking story, but a new report identifies some head-spinning facts behind the focal shift from blockbuster to rare-disease drugs.

#3

Pfizer, Novartis Align Against Liver Disease | Blog

Pfizer and Novartis have been independently developing therapies for nonalcoholic steatohepatitis (NASH), and they’re now set to join forces to yield a combination therapy for the fatty liver disease linked closely with metabolic disorders.

#4

Roche’s “Floodlight” a Multiple Sclerosis Game Changer | Blog

Pharmaceutical giant Roche’s new app for people with multiple sclerosis (MS) revolutionizes how doctors care for patients with the disease.

#5

Snapchat: We’re the Best Social Platform for Pharma Ads | Blog

Deploying ambassadors to speak at the marketing conference DigiPharma Connect, Snapchat is vying to position itself as the best social media outlet for pharma marketing.

#6

Amazon Starts Marketing Its Prescription Drugs | Blog

Last week, many Amazon Prime members received more than their usual flow of order confirmations and shipping notifications, with the retail leviathan inviting some users to “Meet PillPack, a new member of the Amazon family.”

#7

Caesars Casino Mogul: Health Care Professionals Have a Lot to Learn from Gambling | Blog

At the BrightInsight Ecosystem Event, which explores use cases and best practices in digital health, Harvard Business School Professor Gary Loveman shared some lessons for health care professionals gleaned from his unconventional career path.

#8

Scientists to Monitor Diabetes Through Color-Changing Tattoos | Blog

Though pioneering a brand-new health-monitoring technology, scientists at the Technical University of Munich are doing it through an ancient art: tattoos.

#9

The New American Doctor and the Marketing She Loathes | Blog

Marked demographic shifts among American doctors are forecasting a new future for the profession.

#10

P2P Networks Huge for COVID-19 Patients, Responders | Blog

Best practices for avoiding the novel corona virus are fairly well publicized, but for people who have contracted COVID-19 guidance can be harder to come by.

#11

Looking Beyond COVID-19, Walgreens to Open Clinics in Underserved Communities | Blog

Ten years after acquiring its competitor Duane Reade, Walgreens has set its sights on a whole different type of growth, announcing its plan to establish doctor’s offices in hundreds of its familiar brick-and-mortar stores.

#12

Insulin Prices Halved by Eli Lilly | Blog

Responding to rampant criticism of rising drug prices, pharma giant Eli Lilly will begin selling an authorized generic of its preeminent insulin therapy, Humalog, at half-price.

#13

Novartis, J&J, and Merck Find Brand-New Data, Showcase Big Healthcare Shifts as Described in the 2019 Health Trend Ten from Syneos Health | Blog

Forecasting next year’s biggest shifts within the healthcare landscape, Syneos Health has released 2019 Health Trend Ten, available for download now, which explicates ten of the trends that will redefine healthcare globally.

#14

Gene Therapy Innovation Now Guided by FDA | Blog

The advent of federal regulatory guidelines for developing gene therapies—which transplant new genes into people’s cells in order to correct disorders—is a crucial moment in the narrative of the still-novel treatment type.

#15

AI Predicts Drug Interactions Like We Never Could | Blog

Complications from drug interactions can present patients with whole new afflictions.

#16

If You’ve Been the Victim of Medical Malpractice, Don’t Yelp About It | Blog

The State Supreme Court just resolved a 10-year battle between the Cleveland Clinic and a former patient, retired U.S.

#17

Alexa, Upend My Fixed Conceptions of Healthcare in America | Blog

Beginning with its acquisition of PillPack, Amazon’s grand entrance into healthcare continues with its partnership with J.P.

#18

Approved: First CBD-based Prescription Drug, for Treatment of Epilepsy | Blog

A landmark approval by the FDA will put the first marijuana-derived prescription drug behind pharmacy counters this fall.

#19

Big Healthcare Brands Warming to Blockchain | Blog

A new Deloitte report explores the near-future of blockchain: how seriously the world’s top executives, including many in healthcare, regard the emerging technology and how soon they might invest in it.

#20

Lyft Offering (Some) Free Rides to the Hospital | Blog

Nonprofit hospital system Partners HealthCare has unveiled a joint venture with Circulation, an on-demand rideshare service, through which Medicare patients receive free rides to their doctor’s offices in non-emergencies.

#21

WalMart May Enlist Doctors to Help Beat Amazon in Tug-of-War | Blog

To retail behemoths, the health care realm is growing irresistible.

#22

Zipline Drones Achieve Universal Health Care Delivery in Rwanda. | Blog

With funding from Google, Stanford, and venture capital giants Sequoia and Andreessen Horowitz, seven-year-old Zipline has already revolutionized health care in Rwanda.

#23

More Clinical Trials for More Women Thanks to Advantia, Elligo | Blog

Advantia Health, a leading-edge medical company committed to empowering women with integrated health care services, announced a new partnership with Elligo Health Research, which will offer Advantia’s clients access to a whole new realm of resources, through clinical trials.

#25

Pharmacists Reduce Opioid Use by 50% in Kaiser Permanente Study | Blog

In a telling new study, pre- and post-surgical efforts by pharmacists yielded staggering effects on patient opioid use.

#26

Medical Data Processing Disrupted by Amazon | Blog

Amazon Web Services (AWS) has unveiled new machine-learning tools reflecting—and beginning to tackle—some of the greatest challenges facing modern medicine.

#27

GSK Gains Targeted Therapy, Footing in Boston with $5.1-billion Tesaro Buy | Blog

GlaxoSmithKline announced that it will acquire Waltham, Massachusetts-based drug company Tesaro, which develops novel cancer treatments, for $5.1 billion cash.

#28

Apps to Push Prescription Drugs Over the Counter | Blog

In the first half of this new year, the United States FDA will incentivize many pharmaceutical brands to make their biggest prescription drugs available over the counter.

#29

Cannabis Firm Tilray Scores Partnership with Novartis | Blog

Tilray, a medical-cannabis producer, has established a new partnership with pharmaceutical giant Novartis, affording the former sales and distribution channels in tens of new countries.

#30

Amazon Deploys Legion of Micro-influencers, Accepting Applications for More | Blog

While the term “micro-influencer” may still sound to you like some flippant, gen-Z farce, the side hustle cum way of life just scored serious validation.